Back to Browse Journals » Therapeutics and Clinical Risk Management » Volume 4 » Issue 1

Factors affecting therapeutic compliance: A review from the patient’s perspective

Authors Jing Jin, Grant Edward Sklar, Vernon Min Sen Oh, Shu Chuen Li

Published 8 February 2008 Volume 2008:4(1) Pages 269—286


Jing Jin1, Grant Edward Sklar1, Vernon Min Sen Oh2, Shu Chuen Li3

1Department of Pharmacy, National University of Singapore, Republic of Singapore; 2Department of Clinical Pharmacology and Therapeutics, Yong Loo Lin School of Medicine, National University of Singapore, Republic of Singapore; 3Discipline of Pharmacy and Experimental Pharmacology, School of Biomedical Sciences, University of Newcastle, Callaghan, Australia

Objective: To explore and evaluate the most common factors causing therapeutic noncompliance.

Methods: A qualitative review was undertaken by a literature search of the Medline database from 1970 to 2005 to identify studies evaluating the factors contributing to therapeutic non-compliance.

Results: A total of 102 articles was retrieved and used in the review from the 2095 articles identified by the literature review process. From the literature review, it would appear that the definition of therapeutic compliance is adequately resolved. The preliminary evaluation revealed a number of factors that contributed to therapeutic non-compliance. These factors could be categorized to patient-centered factors, therapy-related factors, social and economic factors, healthcare system factors, and disease factors. For some of these factors, the impact on compliance was not unequivocal, but for other factors, the impact was inconsistent and contradictory.

Conclusion: There are numerous studies on therapeutic noncompliance over the years. The factors related to compliance may be better categorized as “soft” and “hard” factors as the approach in countering their effects may differ. The review also highlights that the interaction of the various factors has not been studied systematically. Future studies need to address this interaction issue, as this may be crucial to reducing the level of non-compliance in general, and to enhancing the possibility of achieving the desired healthcare outcomes.

Keywords: patient compliance, adherence, factors

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at:

Readers of this article also read:

Engineered collagen hydrogels for the sustained release of biomolecules and imaging agents: promoting the growth of human gingival cells

Choi J, Park H, Kim T, Jeong Y, Oh MH, Hyeon T, Gilad AA, Lee KH

International Journal of Nanomedicine 2014, 9:5189-5201

Published Date: 11 November 2014

Amantadine and cognitive flexibility: decision making in Parkinson's patients with severe pathological gambling and other impulse control disorders

Cera N, Bifolchetti S, Martinotti G, Gambi F, Sepede G, Onofrj M, Di Giannantonio M, Thomas A

Neuropsychiatric Disease and Treatment 2014, 10:1093-1101

Published Date: 17 June 2014

Psychomotor approach in children affected by nonretentive fecal soiling (FNRFS): a new rehabilitative purpose

Esposito M, Gimigliano F, Ruberto M, Marotta R, Gallai B, Parisi L, Lavano SM, Mazzotta G, Roccella M, Carotenuto M

Neuropsychiatric Disease and Treatment 2013, 9:1433-1441

Published Date: 19 September 2013

Preparation of poly(ethylene glycol)/polylactide hybrid fibrous scaffolds for bone tissue engineering

Ni P, Fu S, Fan M, Guo G, Shi S, Peng J, Luo F, Qian Z

International Journal of Nanomedicine 2011, 6:3065-3075

Published Date: 30 November 2011

Memecylon edule leaf extract mediated green synthesis of silver and gold nanoparticles

Elavazhagan T, Arunachalam KD

International Journal of Nanomedicine 2011, 6:1265-1278

Published Date: 21 June 2011

Tegaserod in the treatment of irritable bowel syndrome (IBS) with constipation as the prime symptom

Peter Layer, Jutta Keller, Helena Loeffler, Andreas Kreiss

Therapeutics and Clinical Risk Management 2007, 3:107-118

Published Date: 15 March 2007